Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa

BACKGROUND: HIV is one of the greatest public health challenges in South Africa. Potential HIV vaccines and antibodies are thought to be cost-effective biomedical HIV prevention methods and are currently under investigation in phase I, II, and III trials. Consequently, current and future clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanass-Hancock, Jill, Carpenter, Bradley, Reddy, Tarylee, Nzuza, Ayanda, Gaffoor, Zakir, Goga, Ameena, Andrasik, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665490/
https://www.ncbi.nlm.nih.gov/pubmed/34895272
http://dx.doi.org/10.1186/s13063-021-05792-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665490/
https://www.ncbi.nlm.nih.gov/pubmed/34895272
http://dx.doi.org/10.1186/s13063-021-05792-7

Ejemplares similares